Results 71 to 80 of about 3,619 (165)
Cellular and animal models for facioscapulohumeral muscular dystrophy
Disease Models & Mechanisms, 2020 Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common forms of muscular dystrophy and presents with weakness of the facial, scapular and humeral muscles, which frequently progresses to the lower limbs and truncal areas, causing profound
Alec M. DeSimone +3 more
doaj +1 more source
Physiological Reports, Volume 14, Issue 12, June 2026.3D muscle culture reproduces the metabolic characteristics associated with the myostatin knockout phenotype. Abstract 3D cell culture, using a variety of bioengineering techniques, enables muscle cells to be cultured in more structural and functional biomimetic conditions than 2D cell culture.
Barbara Vernus +8 more
wiley +1 more source
Turkish Journal of Anaesthesiology and ReanimationFacioscapulohumeral muscular dystrophy (FSHD) is a muscular dystrophy that can affect individuals of all age groups. Its prevalence is reported to be 0.4-1 in 10,000 people. Because of the low occurrence of FSHD, anaesthetic management is primarily based
Mete Manici +4 more
doaj +1 more source
Advanced microscopic and histochemical techniques: diagnostic tools in the molecular era of myology
European Journal of Histochemistry, 2009 Over the past two centuries, myology (i.e. the basic and clinical science of muscle and muscle disease) has passed through 3 stages of development: the classical period, the modern stage and the molecular era.
G Meola
doaj +1 more source
Creatine Phosphokinase in Facioscapulohumeral Muscular Dystrophy [PDF]
BMJ, 1971 Study of the serum creatine kinase levels in young patients with facioscapulohumeral muscular dystrophy suggests that enzyme assay may be valuable as a screening procedure for assessing the status of relatives of an affected individual who have no previous clinical history, and that consequently it may be of use in genetic counselling.
openaire +2 more sources
Elderly Onset of Weakness in Facioscapulohumeral Muscular Dystrophy
Case Reports in Neurological Medicine, 2012 A 77-year-old male is presented. He had onset of proximal weakness 10 years earlier. His course was slowly progressive. Despite having phenotypic features of facioscapulohumeral muscular dystrophy (FSH), genetic testing for this was delayed because of ...
Dominic B. Fee
doaj +1 more source
[Facioscapulohumeral muscular dystrophy]. [PDF]
Nederlands tijdschrift voor tandheelkunde, 2010 Facioscapulohumeral muscular dystrophy is clinically mainly characterized by progressive weakness of the facial, shoulder and upper arm muscles. It is an autosomal dominant heriditary disease, caused by a contraction of a repetitive DNA element at the end of the long arm of chromosome 4.
Wilbers, J. +4 more
openaire +2 more sources
Advances in imaging of brain abnormalities in neuromuscular disease
Therapeutic Advances in Neurological Disorders, 2019 Brain atrophy, white matter abnormalities, and ventricular enlargement have been described in different neuromuscular diseases (NMDs). We aimed to provide a comprehensive overview of the substantial advancement of brain imaging in neuromuscular diseases ...
Corrado Angelini, Elena Pinzan
doaj +1 more source
A Case of Facioscapulohumeral Muscular Dystrophy
International Journal of Medical StudentsBackground: Facioscapulohumeral muscular dystrophy (FSHMD) is a genetically determined, progressive skeletal muscle disorder characterized by a distinctive pattern of muscle involvement, variable clinical severity, and significant diagnostic challenges.
Neha Sahota, Shubreet Randhawa
doaj
Revista Pesquisa em Fisioterapia| INTRODUCTION: Facioscapulohumeral muscular dystrophy (FSHD) is prevalent innate autosomal dominant form of muscular dystrophy (MD) involving asymmetrical progression of muscle weakness.
Angel Gupta +4 more
doaj +1 more source